26.07 (-%)
As of Dec 03, 2024
Source:
Arrowhead Pharmaceuticals, Inc develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, the Company’s therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes.
Country | United States |
Headquarters | pasadena, california |
Phone Number | 626-696-4702 |
Industry | manufacturing |
CEO | Christopher Anzalone |
Website | www.arrowheadpharma.com |